J2KBIO Co., Ltd. (KOSDAQ:420570)
South Korea · Delayed Price · Currency is KRW 9,220.00
+10.00 (0.11%)
At close: Sep 23, 2026
J2KBIO Market Cap
J2KBIO has a market cap or net worth of 53.91 billion as of September 25, 2026. Its market cap has decreased by -6.01% in one year.
Market Cap
53.91B
Enterprise Value
45.05B
Revenue
43.90B
Ranking
n/a
PE Ratio
9.27
Stock Price
9,220.00
ChartMarket Cap Chart
Since March 25, 2024, J2KBIO's market cap has decreased from 144.93B to 53.91B, a decrease of -62.80%. That is a compound annual growth rate of -32.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 53.91B | 7.21% |
| Dec 30, 2025 | 50.29B | -3.28% |
| Dec 30, 2024 | 52.00B | -64.12% |
| Mar 25, 2024 | 144.93B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NovMetaPharma | 67.93B |
| PanGen Biotech | 64.94B |
| ABION | 60.91B |
| Psomagen | 59.92B |
| TegoScience | 57.57B |
| CHOOLIP & SCIENCES | 56.28B |
| KoBioLabs | 51.75B |
| QuadMedicine | 51.04B |